news sent imcera share tumbl $ 4.125 almost
12 % $ 34.125 late new york stock exchang composit
trade volum extrem heavi 3.5 million share
trade hand
compani said temporarili suspend sale
number anim drug pend complet qualiti
certif process way kansa
animal-product plant matter confin technic
manufactur control imcera said ad
reason believ safeti efficaci problem
whatsoev product alreadi releas sold
hear fda imcera said
know whether impact inspect
six cent per share someth less determin
factor length sale suspens
cost correct defici said
addit compani said analyst probabl
optimist estim earn continu
oper fiscal year end june 30 would exceed
$ 1.65 share even exclud potenti charg
compani previous pronounc comfort
estim cite continu price pressur
feed-ingredi busi pitman-moor unit
fiscal six month imcera earn
continu oper $ 53.4 million 68 cent
share $ 2 million loss discontinu oper trim
per-shar net two cent sale $ 801.5 million
imcera also interest specialti chemic
medic product
